eXoZymes increases CEO base salary to $450K, grants options and $250K bonus

EXOZYMES INC.

CEO Michael Heltzen base salary raised to $450,000 annualized.
Granted options to purchase 235,817 shares at $12.40 per share, vesting quarterly over 4 years.
One-time bonus of $250,000 approved.
Options vesting starts July 1, 2025; expires June 29, 2032.

item 5.02 item 9.01

EXOZYMES INC. filing history →

Source: SEC EDGAR

accession 0001641172-25-015782

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.